Holen Sie sich die Stockscreener-App
279.21
0.75%
2.08
Vorhandelsmarkt:
279.44
0.23
+0.08%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$277.13
Offen:
$278.85
24-Stunden-Volumen:
2.96M
Relative Volume:
1.02
Marktkapitalisierung:
$157.78B
Einnahmen:
$34.13B
Nettoeinkommen (Verlust:
$5.93B
KGV:
25.48
EPS:
10.96
Netto-Cashflow:
$10.92B
1W Leistung:
+2.48%
1M Leistung:
-3.11%
6M Leistung:
+7.12%
1J Leistung:
-10.64%
1-Tages-Spanne:
$276.58
$280.04
1-Wochen-Bereich:
$269.01
$286.17
52-Wochen-Spanne:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
279.21 | 157.78B | 34.13B | 5.93B | 10.92B | 10.96 |
|
LLY
Lilly Eli Co
|
779.53 | 724.64B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
152.75 | 376.43B | 89.33B | 21.81B | 18.57B | 8.99 |
|
NVO
Novo Nordisk Adr
|
69.02 | 352.49B | 43.59B | 15.04B | 10.74B | 3.3766 |
|
ABBV
Abbvie Inc
|
185.62 | 334.73B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
121.01 | 234.21B | 53.22B | 12.86B | 14.85B | 6.39 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Trust Point Inc. Has $411,000 Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sagespring Wealth Partners LLC Sells 2,343 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (AMGN) to Present Key Study Findings at Diabetes Conference - GuruFocus
Amgen to present data from mid-stage obesity study (AMGN:NASDAQ) - Seeking Alpha
Amgen (AMGN) to Present Key Study Results at Diabetes Conference - GuruFocus
AMGEN'S PHASE 2 MARITIDE DATA TO BE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS | AMGN Stock News - GuruFocus
Revolutionary Monthly Obesity Treatment MariTide Achieves Continuous Weight Loss at 52 Weeks - Stock Titan
CWA Asset Management Group LLC Has $7.16 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Clarius Group LLC Has $3.20 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Mn Services Vermogensbeheer B.V. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Position Decreased by New Century Financial Group LLC - MarketBeat
Amgen Boosts Growth With Strong Q1 Results and $1.9B Infrastructure Investment - MSN
Members of Congress Are Pouring Millions Into These 7 Surprising Stocks - The Motley Fool
Investing in Amgen (NASDAQ:AMGN) five years ago would have delivered you a 47% gain - Yahoo Finance
8,490 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Lesa Sroufe & Co - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Reduced by PKO Investment Management Joint Stock Co - MarketBeat
CENTRAL TRUST Co Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Chicago Capital LLC Sells 1,212 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Consilium Wealth Advisory LLC Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
AA Financial Advisors LLC Takes $524,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sowell Financial Services LLC Sells 1,054 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Elevation Point Wealth Partners LLC Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Saudi Arabia Signs Multiple Healthcare Deals, Partnerships at BIO 2025 - MarketScreener
Amgen’s Strong Cash Flow Supports Reliable Dividend Payments - MSN
New England Research & Management Inc. Sells 2,926 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Renews Push for Colorado Payment Cap Halt At Appeals Court - Bloomberg Law News
Amgen Inc. (NASDAQ:AMGN) Stock Position Increased by Precedent Wealth Partners LLC - MarketBeat
QRG Capital Management Inc. Buys 4,945 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Janney Montgomery Scott LLC Acquires 35,100 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Cyndeo Wealth Partners LLC - MarketBeat
EHA 2025: Regeneron’s Lynozyfic with Amgen’s Kyprolis combo emerges for R/R MM - Yahoo Finance
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Fort Washington Investment Advisors Inc. OH - MarketBeat
Hanson & Doremus Investment Management Raises Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Argus Investors Counsel Inc. Trims Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Birch Capital Management LLC Has $7.41 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
NorthCrest Asset Manangement LLC Grows Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by North Star Investment Management Corp. - MarketBeat
Brighton Jones LLC Raises Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Ritholtz Wealth Management Has $4.08 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Foster Victor Wealth Advisors LLC Has $13.78 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH - MarketBeat
Amgen Announces Significant Survival Benefit for Lung Cancer Drug IMDELLTRA in Phase 3 Trial - MSN
Dynamic Advisor Solutions LLC Purchases 1,591 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Holdings Trimmed by Greenwood Capital Associates LLC - MarketBeat
CX Institutional Sells 3,410 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen’s SWOT analysis: stock outlook amid obesity drug race - Investing.com
Franklin Street Advisors Inc. NC Sells 21,974 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
2,918 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Davis Investment Partners LLC - MarketBeat
Ferguson Wellman Capital Management Inc. Purchases 170,577 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen: Imdelltra Data And Q1 Results Impress - Seeking Alpha
Amgen (AMGN) Stock Rally Hits Wall of Resistance in Volatile Trading Session - Daily Chhattisgarh News
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):